You seem to be using an outdated version of Internet Explorer. Please note that this site does not support this browser version (a href="http://windows.microsoft.com/de-de/windows/end-support-help">as does Microsoft). You may experience design inconsistencies and error messages. We are sorry for any inconveniences.

News

GeneQuine Biotherapeutics’ Gene Therapy Program for Treatment of Knee Osteoarthritis Acquired by Flexion Therapeutics

14. December 2017
Knee osteoarthritis program developed by Hamburg-based gene therapy specialist GeneQuine Biotherapeutics acquired by Flexion Therapeutics for up to $64 million. Program holds potential to provide long-lasting pain relief and disease modification, and pending positive pre-clinical results is anticipated to enter clinical trials in 2019. GeneQuine Biotherapeutics GmbH today announced that Flexion Therapeutics, Inc. (Nasdaq: FLXN) has acquired the global rights More …

Scipio bioscience announces its seed funding

14. November 2017
Scipio bioscience, a Paris-based biotechnology company devoted to providing a novel sample preparation solution for single-cell studies in the form of benchtop kits, announces today the completion of its initial fundraising. A total of €1.2m has been obtained from two European seed funds: Paris, France-based Seventure Partners’ Quadrivium I seed fund and Bonn, Germany-based High-Tech Gründerfonds. These funds will fuel More …

Focus on Medical Device Regulation: BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM publish “MedTech Radar 9”

13. November 2017
The EU Medical Device Regulation heralds a new era for the medical technology sector: in future, any company wishing to bring medical devices to market must face the requirements of this new regulatory framework. This implies a sizeable challenge for the many small and medium-sized enterprises in Germany. The 9th edition of the joint media service “MedTech Radar”, published by More …

Dresden Memory Start-up Ferroelectric Memory Company (FMC) Receives Seed Investment by HTGF

26. October 2017
Higher speed, extremely low power: The Ferroelectric Memory Company (FMC) brings a new semiconductor memory to market. The technology revolutionizes how people interact with applications ranging from smart watches to self-driving cars. FMC received a seed investment from HTGF to implement first memory IP products by 2018. FMC provides the 17B€ microcontroller industry a future-proof memory technology. For non-volatile storage, More …

Seed financing round for sensor startup Blickfeld paves the way for autonomous driving

24. October 2017
A so far missing piece of autonomous vehicles are cost-efficient laser-based 3D sensors, also known as LiDAR (Light Detection and Ranging). The Munich-based startup company Blickfeld develops such sensor systems and was now able to raise EUR 3.6 million in a seed financing round from Fluxunit – OSRAM Ventures, High-Tech Gründerfonds, Tengelmann Ventures, und Unternehmertum Venture Capital Partners. Autonomous systems, More …

Venture capital: RWE Generation invests in HTGF III

19. October 2017
RWE Generation SE has announced a strategic investment in High-Tech Gründerfonds’ third fund, HTGF III, which is launching with a planned volume of over EUR 300 million. High-Tech Gründerfonds (HTGF) is Germany’s most active seed stage investor. It provides financing for young, innovative technology-driven start-ups and actively supports them in implementing their business ideas. “Through this investment, we are seeking More …

The game changer in surgical education – breaking bones for better patient outcomes

10. October 2017
Cologne based MedTech start-up RIMASYS received financing from investor HTGF. The investment will be utilized to expand the fracture portfolio, upgrade production technology and increase international reach. RIMASYS is the worldwide sole manufacturer of life-like fractures in human specimen with intact soft tissue mantle. Enabling medical science to enhance surgical skills and the health care industry to develop better implants More …

OMEICOS Secures Extension of Series B Financing Round to Expand its Technology into Ophthalmology

4. October 2017
OMEICOS adds REMIGES Ventures as new investor and announces the incorporation of U.S. subsidiary OMEICOS Ophthalmics, Inc. OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases, today announced that it has secured an extension of its recently closed Series B financing round. The financing by US-based REMIGES Ventures will help More …

High-Tech Gründerfonds starts lining up investments for HTGF III fund

15. September 2017
Europe’s most active seed-stage investor announces first investments from third fund, HTGF III High-Tech Gründerfonds’ third fund is now operational After announcing the successful first close at the 2017 Family Day – the biggest event of the year for the venture capital sector in Germany – HTGF has now begun approving investments from the new fund. The launch coincides with More …

MSD to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology

6. September 2017
MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK)), and Rigontec today announced that MSD will acquire Rigontec. Rigontec is a pioneer in accessing the retinoic acid-inducible gene I (RIG-I) pathway, part of the innate immune system, as a novel and distinct approach in cancer immunotherapy to induce both immediate and long-term anti-tumor immunity. Under the terms More …